Study Evaluating the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease
Status:
Completed
Trial end date:
2021-09-03
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate whether selonsertib (SEL) can slow the
decline in kidney function in participants with moderate to advanced diabetic kidney disease
(DKD).